Skip to main content
Premium Trial:

Request an Annual Quote

CapitalBio to Provide Roche NimbleGen Array Services in China


By Justin Petrone

Chinese genomic services provider CapitalBio has joined the Roche NimbleGen certified service provider program, Roche said last week.

Beijing-based CapitalBio has been certified to offer NimbleGen gene expression, comparative genomic hybridization and copy number variation, and DNA methylation services to Asian customers.

CapitalBio is also the first NimbleGen certified service provider in Asia to implement the MS 200 Microarray Scanner into its array workflow for high-resolution scanning, Roche said. Korea's DNA Link was certified by Roche in October to offer target enrichment services on NimbleGen sequence capture arrays (see BAN 10/20/2009).

Andreas Görtz, vice president of marketing for Roche NimbleGen, said in a statement that the certification positions the Madison, Wis.-based array company for "tremendous future growth in this rapidly developing market."

Junquan Xu, vice president of operations at CapitalBio, in a statement called the certification a "major step forward in our efforts to bring advanced DNA analysis to China." Founded in 2000, CapitalBio employs nearly 400 people and sells its own portfolio of arrays and instrumentation. CapitalBio is also a certified Affymetrix services provider.

Financial details were not discussed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.